| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ca7e29f825a42ad09e0ea69c2fb49a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ee0668bab75dab5aece6e92a16bce8 |
| publicationDate |
2009-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090011849-A |
| titleOfInvention |
APTAMER SPECIFIC TO TGF-beta2 LIGAND GENE AND ANTI-CANCER COMPOSITION COMPRISING THE SAME |
| abstract |
The present invention describes aptamer-bound nanocarriers by the TGF-β2 ligand gene, a cancer-containing composition comprising the same, and a method for treating or diagnosing cancer using the same. |
| priorityDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |